Skip to main content
. Author manuscript; available in PMC: 2022 Jul 1.
Published in final edited form as: J Immunol. 2021 Jun 16;207(1):110–114. doi: 10.4049/jimmunol.2100046

Figure 3.

Figure 3.

PD-L1 optimizes AM phagocytosis. (A) Superior phagocytic ability of AMs in comparison to IMs (n = 6). (B) No PD-L1 expression on the AMs of PD-L1 deficient (PD-L1KO) mice. (C) Decreased phagocytic ability of PD-L1KO AMs (n >= 7). Student’s t test was performed (two tailed, unpaired) and data represent means ± SEM in (A, C). **P < 0.01.